Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Targeting immune cells in the aged brain reveals that engineered cytokine IL-10 enhances neurogenesis and improves cognition.

Immunity·2026

Same author

De novo design of RNA pseudoknots with deep learning.

bioRxiv : the preprint server for biology·2026

Same author

A generalizable system for antigenic peptide targeting across HLA-I allotypes.

bioRxiv : the preprint server for biology·2026

Same author

Deep peptide recognition profiling decodes TCR specificity and enables disease-associated antigen discovery.

Nature biotechnology·2026

Same author

Zero-shot design of a <i>de novo</i> metalloenzyme.

bioRxiv : the preprint server for biology·2026

Same author

Viral vector-free generation of orthogonal IL-2-responsive CAR T cells through gene editing of IL-2 and its receptor.

Blood immunology & cellular therapy·2026

Same journal

Tau protein as a regulator of mitochondrial function and dynamics.

Proceedings of the National Academy of Sciences of the United States of America·2026

Same journal

A scalable, dividing cell model for the robust propagation and quantification of human sporadic Creutzfeldt-Jakob disease prions.

Proceedings of the National Academy of Sciences of the United States of America·2026

Same journal

Epigenetic regulation of mesenchymal BMP signaling directs postnatal organ innervation.

Proceedings of the National Academy of Sciences of the United States of America·2026

Same journal

Single-shot wide-field biochemical imaging at 1 kHz frame rate.

Proceedings of the National Academy of Sciences of the United States of America·2026

Same journal

Morphogenesis and topological evolution of a frustrated nematic liquid crystal under confinement.

Proceedings of the National Academy of Sciences of the United States of America·2026

Same journal

B cell-intrinsic CXCR3 drives efficient generation of ectopic pulmonary germinal center responses to influenza A virus infection.

Proceedings of the National Academy of Sciences of the United States of America·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Sep 30, 2025

An ELISA Based Binding and Competition Method to Rapidly Determine Ligand-receptor Interactions

An ELISA Based Binding and Competition Method to Rapidly Determine Ligand-receptor Interactions

Published on: March 14, 2016

Interleukin-2 superkines by computational design.

Junming Ren^1,2, Alexander E Chu^3,4, Kevin M Jude^1,2

¹Department of Molecular and Cellular Physiology, Stanford University School of Medicine, Stanford, CA 94305.

Proceedings of the National Academy of Sciences of the United States of America

|March 16, 2022

Summary

This summary is machine-generated.

Computational design enhanced interleukin-2 (IL-2) binding affinity by stabilizing its structure, not by engineering interfaces. This approach yielded IL-2 variants with significantly improved therapeutic potential for T and NK cells.

Keywords:

immunology in silico design protein engineering structural biology

More Related Videos

Ex vivo Expansion of Tumor-reactive T Cells by Means of Bryostatin 1/Ionomycin and the Common Gamma Chain Cytokines Formulation

Ex vivo Expansion of Tumor-reactive T Cells by Means of Bryostatin 1/Ionomycin and the Common Gamma Chain Cytokines Formulation

Published on: January 14, 2011

Isolation and Expansion of Cytotoxic Cytokine-induced Killer T Cells for Cancer Treatment

Isolation and Expansion of Cytotoxic Cytokine-induced Killer T Cells for Cancer Treatment

Published on: January 24, 2020

Related Experiment Videos

Last Updated: Sep 30, 2025

An ELISA Based Binding and Competition Method to Rapidly Determine Ligand-receptor Interactions

An ELISA Based Binding and Competition Method to Rapidly Determine Ligand-receptor Interactions

Published on: March 14, 2016

Ex vivo Expansion of Tumor-reactive T Cells by Means of Bryostatin 1/Ionomycin and the Common Gamma Chain Cytokines Formulation

Ex vivo Expansion of Tumor-reactive T Cells by Means of Bryostatin 1/Ionomycin and the Common Gamma Chain Cytokines Formulation

Published on: January 14, 2011

Isolation and Expansion of Cytotoxic Cytokine-induced Killer T Cells for Cancer Treatment

Isolation and Expansion of Cytotoxic Cytokine-induced Killer T Cells for Cancer Treatment

Published on: January 24, 2020

Area of Science:

Biochemistry
Protein Engineering
Immunology

Background:

Affinity maturation of protein-protein interactions is crucial for developing therapeutic proteins like cytokines.
Current methods often focus on interface engineering, overlooking scaffold stabilization.

Purpose of the Study:

To demonstrate computational design's ability to enhance IL-2 affinity without interface engineering.
To explore structure-guided stabilization as a strategy for cytokine affinity maturation.

Main Methods:

Utilized computational design to globally stabilize the interleukin-2 (IL-2) structure, targeting metastable regions.
Focused on structural stabilization rather than direct engineering of receptor binding interfaces.

Main Results:

Developed thermostable IL-2 variants with up to 40-fold increased affinity for IL-2Rβ.
Achieved enhanced affinity without library-based optimization or interface modifications.
Designed IL-2 analogs with CD25-independent activity on T and NK cells, both in vitro and in vivo.

Conclusions:

Structure-guided stabilization of cytokines is a potent method for affinity maturation.
This computational approach offers a novel strategy for developing enhanced therapeutic cytokines and improving protein-protein interactions.